TopFunds

Drug Manufacturers General

Companies

11 companies

LIST VIEW

11 companies
Valuation
Historical Performance:
Fundamentals
Sort by:
01
Eli Lilly And Co LLY

1,257 (+0.4)%

42.2
1.8%
-
-
-
18.4%
77.8%

1.6

02
Johnson & Johnson JNJ

255.6 (+0.9)%

38.7
1.7%
-
-
-
13.5%
32.9%

-

03
AbbVie Inc. ABBV

285.4 (+0.7)%

80.4
3.6%
-
-
-
3.2%
(130.9)%

3.3

04
Merck & Co., Inc. MRK

146 (+0.5)%

116.8
4.4%
-
-
-
13.3%
34.7%

2.4

05
Amgen Inc. AMGN

432.5 (-0.4)%

26.9
4.3%
-
-
-
8.5%
89.1%

3.5

06
Gilead Sciences, Inc. GILD

156.2 (-0.7)%

(58.5)
6.8%
-
-
-
14.4%
37.6%

1.7

07
Novo Nordisk A/S NVO

38.8 (-1)%

9.9
4.3%
-
-
-
18.9%
52.8%

0.7

08
Pfizer Inc. PFE

29.6 (+0.5)%

39.1
6.5%
-
-
-
3.7%
9%

4.6

09
Bristol-Myers Squibb Company BMY

59.8 (-1.4)%

13.2
9.4%
-
-
-
7.8%
38.1%

2.7

10
Biogen BIIB

232.7 (-1.1)%

41.2
8.7%
-
-
-
4.4%
7.1%

2.5

11
Zoetis ZTS

79.3 (+1.1)%

13.1
6.9%
-
-
-
17.3%
80.3%

2.7

Total
Help

Assumes equal weights for the Base and Lens views. The Holdings view is position-weighted.

(-0)%
33
5.3%
271.4%
0%
0%
11.2%
29.8%
2.3